[Comparison of different definitions on metabolic syndrome in obese children]

Qi-yu Fang1, Yan-ping Wan, Jia-lu Wang

  • 1Department of Clinical Nutrition, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200001, China.

Insights

The Cook, et al. and da Silva, et al. definitions are more suitable for diagnosing metabolic syndrome (MS) in obese children, especially when considering insulin resistance. Both American and Chinese cutoff values are effective for MS diagnosis in Chinese pediatric populations.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • Metabolic syndrome (MS) is a growing concern in obese children.
  • Multiple definitions exist for pediatric MS, leading to potential discrepancies in prevalence rates.
  • Choosing an appropriate definition is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To compare the prevalence of MS in obese children using three common pediatric definitions: International Diabetes Federation (IDF), Cook, et al., and da Silva, et al.
  • To evaluate the impact of American versus Chinese cutoff values on MS prevalence.
  • To identify the most suitable MS definition for Chinese obese children.

Main Methods:

  • Retrospective study of 136 obese children (7-18 years) from an outpatient program.
  • Exclusion of children with hereditary endocrine/metabolic diseases, secondary obesity, or significant organ dysfunction.
  • Measurement of anthropometrics, blood pressure, lipids, glucose, and insulin; calculation of HOMA for insulin resistance.
  • Application of American and Chinese cutoff values for central obesity and hypertension.

Main Results:

  • MS prevalence varied significantly by definition: IDF (19.2%), Cook, et al. (34.6-43.4%), and da Silva, et al. (52.9-58.1%).
  • The Cook, et al. and da Silva, et al. definitions showed better agreement with each other (Kappa 0.51-0.52) compared to IDF.
  • Children diagnosed with MS by Cook, et al. or da Silva, et al. exhibited higher insulin resistance.

Conclusions:

  • Metabolic syndrome prevalence is high in obese pediatric outpatients, influenced by the chosen definition.
  • The Cook, et al. and da Silva, et al. definitions appear more appropriate for diagnosing MS in obese children, particularly when insulin resistance is a factor.
  • Both American and Chinese cutoff values are viable for MS diagnosis in this population.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...